These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 8456425

  • 1. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL.
    Thromb Haemost; 1993 Feb 01; 69(2):130-4. PubMed ID: 8456425
    [Abstract] [Full Text] [Related]

  • 2. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J.
    J Clin Invest; 1990 Aug 01; 86(2):385-91. PubMed ID: 2384594
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy.
    Brill-Edwards P, Van Ryn-McKenna J, Cai L, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1992 Oct 05; 68(4):424-7. PubMed ID: 1448774
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J, Stöhr HA, Stauss H, Koschinsky R, Stüber W, Pâques EP.
    Thromb Haemost; 1994 Mar 05; 71(3):320-4. PubMed ID: 8029796
    [Abstract] [Full Text] [Related]

  • 6. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb 05; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of local inhibition of procoagulant activity associated with small-diameter prosthetic vascular grafts.
    Oltrona L, Eisenberg PR, Abendschein DR, Rubin BG.
    J Vasc Surg; 1996 Oct 05; 24(4):624-31. PubMed ID: 8911411
    [Abstract] [Full Text] [Related]

  • 8. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I, Finkle CD, Winocour PD.
    Thromb Haemost; 1998 Jul 05; 80(1):186-91. PubMed ID: 9684808
    [Abstract] [Full Text] [Related]

  • 9. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT, Paul W, Emerson M, Cicala C, Page CP.
    Eur J Pharmacol; 1994 Oct 24; 264(2):183-90. PubMed ID: 7851481
    [Abstract] [Full Text] [Related]

  • 10. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1990 Apr 12; 63(2):204-7. PubMed ID: 2363121
    [Abstract] [Full Text] [Related]

  • 11. A quantitative thrombin time for determining levels of hirudin and Hirulog.
    Reid TJ, Alving BM.
    Thromb Haemost; 1993 Oct 18; 70(4):608-16. PubMed ID: 8115987
    [Abstract] [Full Text] [Related]

  • 12. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH.
    Annu Rev Med; 1994 Oct 18; 45():165-77. PubMed ID: 8198374
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW.
    Thromb Haemost; 1994 Sep 18; 72(3):377-80. PubMed ID: 7855787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN, Girardot C, Lecoffre C, Lunven C.
    Thromb Haemost; 1994 Sep 18; 72(3):381-6. PubMed ID: 7855788
    [Abstract] [Full Text] [Related]

  • 18. The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.
    Linder R, Frebelius S, Grip L, Swedenborg J.
    Thromb Res; 2003 Jun 01; 110(4):221-6. PubMed ID: 14512086
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.